BMS-833923

Inquiry

Cat. No.: DIA-0231152

Size: 50 mg Size: 500 mg Size: Customer Size

Product Information
CAS No.	1059734-66-5
Synonyms	XL139
Formula	C₃₀H₂₇N₅O
Molecular Weight	473.57
SMILES	CNCC1=CC(=C(C)C=C1)NC(=O)C2=CC=C(NC3=NC4=CC=CC=C4C(=N3)C5=CC=CC=C5)C=C2
Product Description	BMS-833923 is an orally bioavailable Smoothened antagonist. Phase 2.

Format & Storage
Purity	> 98%
Shipping	Shipped on dry ice.
Storage	Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month
Solubility Overview	Soluble in DMSO

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links

Contact Info

Top